{"name":"OncoVerity, Inc.","slug":"oncoverity-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ARGX-110","genericName":"ARGX-110","slug":"argx-110","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ARGX-110","genericName":"ARGX-110","slug":"argx-110","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE55dWp1cV8wdXVDamo2Mjc1N2hQNUhtbFpQMDhaYUZrTlJRSElXNmRXZjdrQlR1U0RIQlpZVkMyaERMRDVFUzBTejNtdWY2MnRHYS13Vg?oc=5","date":"2024-11-26","type":"pipeline","source":"The Pharma Letter","summary":"OncoVerity - The Pharma Letter","headline":"OncoVerity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPdmliVGI2d1ZMRVdVbTZtWEpTWnNoVlJlQVlJUWtra28yOFh2Y2dEU2NpQ1F4YkM5OWttV1d4M21hVEJELUNmNVpWQ2hsZGRCYjdfdGRwdmxuQW9RelBHcFVzY19XcmZpQUIxQTh1ZDltbnVCS19lVEdkanJkQlBWa2RsSEVxUXNZcklNcGNUUFBXZ1pjWHRvckVzNA?oc=5","date":"2024-09-24","type":"pipeline","source":"Pharmaceutical Executive","summary":"Max Colao Shares How OncoVerity is Pioneering Oncology Solutions - Pharmaceutical Executive","headline":"Max Colao Shares How OncoVerity is Pioneering Oncology Solutions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNdXZYSVNTX0szU2JkX293X21iYmw3cHdZWFpOMEJZX25CS215T2N2Q24wOTVoaEd5enplNkN6QTVvWWtFYS1LUnVBV1QxVHFYNkVydkxHaEtCazIyZVlwRGQteDNsazcwbEZSQXh5bG81a0FaU0pNV1hUdUdnMjJkag?oc=5","date":"2023-12-20","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQT3pXSGtSSHRqRVJCT2c2akZNdEx4b3YwdzBpbFRpNGpJX1lvcVFMem9pd2hrdzNzWGV5SFVFdEU5Q1NPSXdWN2FXTVVEZWVzdUNzM0o4X292Y1RlUExuUWNoNE4tckREbjFzb0psVEF4Z294OC10YXZzdlVxcExZVkNSLXVJS1VZZkloYjA3ZS1yN0FpWkVkcHJQZTB3RlVFZUlydnlwdXJSNEh5c2FkV3hldUl4ck9T?oc=5","date":"2023-03-28","type":"pipeline","source":"Pharmaceutical Technology","summary":"OncoVerity eyes cusatuzumab development in AML after licensing rights - - Pharmaceutical Technology","headline":"OncoVerity eyes cusatuzumab development in AML after licensing rights -","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}